Bottom line
Is SIXL a good fund? The bottom line
SIXL is an actively managed large blend ETF from Innovator.
Its expense ratio is 0.46% — about $46 a year on every $10,000 invested, cheaper than 80% of large blend funds we track.
It returned +1.2% over one year, +5.5% a year over five years (as of Dec 31, 2024, per its prospectus).
With $189 million in net assets and 241 holdings, its largest position is Progyny Inc (0.6%) and the top 10 make up 5.5% of the portfolio.
What stands out
- Low cost: cheaper than 80% of large blend peers
- Broadly diversified (241 holdings)
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What SIXL invests in
The ETC 6 Meridian Low Beta Equity Strategy ETF (the Fund) seeks to provide capital appreciation.
The Fund is an actively managed exchange-traded fund (ETF) that invests, under normal circumstances, at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities. The equity securities in which the Fund invests are mainly common stocks. The Fund may invest in equity securities of companies of any capitalization. The Fund also may invest in real estate investment trusts (REITs). In selecting investments for the Fund, Madison Avenue Financial Solutions, LLC, the Funds sub-adviser (the Sub-Adviser), uses a quantitatively-driven strategy designed to emphasize high quality securities with a relatively low exposure to broad equity market risk. Pursuant to this strategy, securities are first ranked on a composite of several variables intended to measure profitability, growth and ability to service financing obligations. Securities ranking the…
From the fund's prospectus (filed Mar 27, 2026).
SIXL performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SIXL | +1.2% | +5.5% | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2024
What SIXL costs
On a $10,000 investment, SIXL's 0.46% expense ratio costs about $46 a year. The prospectus estimates $579 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
SIXL top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Progyny Inc | 0.63% |
| 2 | Elevance Health, Inc. | 0.59% |
| 3 | Tg Therapeutics, Inc. | 0.56% |
| 4 | Davita Inc. | 0.56% |
| 5 | Whitestone REIT | 0.55% |
| 6 | Ezcorp, Inc. | 0.54% |
| 7 | Virtu Financial, Inc. | 0.53% |
| 8 | Exelixis, Inc. | 0.53% |
| 9 | Ul Solutions Inc. | 0.53% |
| 10 | Sensient Technologies Corporation | 0.53% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 5.5% of the fund. See all top 25 holdings and asset mix →